Intraarterial route increases the risk of cerebral lesions after mesenchymal cell administration in animal model of ischemia
Year: 2017
Type: article
Abstract: Mesenchymal stem cells (MSCs) are a promising clinical therapy for ischemic stroke. However, critical parameters, such as the most effective administration route, remain unclear. Intravenous (i.v.) and intraarterial (i.a.) delivery routes have yielded varied outcomes across studies, potentially due to the unknown MSCs distribution. We investigated whether MSCs reached the brain following i.a. or i.v. administration after transient cerebral ischemia in rats, and evaluated the therapeutic effects of both routes. MSCs were labeled with dextran-coated superparamagnetic nanoparticles for magnetic resonance imaging (MRI) cell tracking, transmission electron microscopy and immunohistological analysis. MSCs were found in the brain following i.a. but not i.v. administration. However, the i.a. route increased the risk of cerebral lesions and did not improve functional recovery. The i.v. delivery is safe but MCS do not reach the brain tissue, implying that treatment benefits observed for this route are not attributable to brain MCS engrafting after stroke.
Source: Scientific Reports
DOI: 10.1038/srep40758
Institutions: Universidade de Santiago de Compostela, Instituto de Investigación Sanitaria de Santiago, IMEC, KU Leuven, Universidad de Guadalajara, Consejo Superior de Investigaciones Científicas, Institut d'Investigacions Biomèdiques de Barcelona, Consorci Institut D'Investigacions Biomediques August Pi I Sunyer
Language: English
Subfield: Cell Biology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $2,690
Awards: Reprogramación in vivo del cerebro isquémico como nueva opción terapéutica en el infarto cerebral, G278247039, G3179589365, G395362047, G434337789, Encapsulación del activador del plasminógeno tisular (tPA) en nanoestructuras vectorizadas y eco-sensibles., G5481562022, G5595930160, PROMOTING ACTIVE AGEING: FUNCTIONAL NANOSTRUCTURES FOR ALZHEIMER’S DISEASE AT ULTRA-EARLY STAGES., G7627042435, G8388323574
OpenAlex ID: W2574930115
